.OH |
Hydroxyl Radicals |
1,3BPG |
1,3 bisphosphoglycerate |
Acetic acid |
AcOH |
ADMET |
Absorption, distribution, metabolism, excretion, toxicity |
Ag85 |
Antigen 85 |
AHLs |
N-acyl homoserine lactones |
AIs |
Auto-inducers |
ALFs |
Shrimp antilipopolysaccharide factors |
Aluminium chloride |
AlCl |
AmB |
Amphotericin B |
AMP |
Antimicrobial peptides |
AMR |
antimicrobial resistance |
API |
Active pharmaceutical ingredient |
ASPs |
Antimicrobial Stewardship Plans |
ATP-ABC |
Adenosine triphosphate-Binding Cassette |
AZT |
Zidovudine |
BBr3 |
Boron tribromide |
BGC |
Biosynthetic gene cluster |
BioA |
7,8- diaminopelargonic acid synthase |
BnBr |
Benzyl bromide |
C2H5I |
Ethyl iodide |
C3Ds |
Cephalosporin-3′-diazeniumdiolates |
C6H6
|
Benzene |
CABP |
Community-acquired bacterial pneumonia |
CBD |
Cannabidiol |
CBG |
Cannabigerol |
CDI |
Carbonyldiimidazole |
CEO |
Cinnamon essential oil |
CFDC |
Cefiderocol |
CH2Cl2
|
Dichloromethane |
CH3CN |
Acetonitrile |
CoAF |
Cobalt nanoferrite |
CPPs |
Cell-penetrating peptides |
CPPs |
Critical process parameters |
CQAs |
Critical quality attributes |
CR |
Carbapenem resistant |
CRAB |
Carbapenem-resistant Acinetobacter baumannii
|
CRE |
Carbapenem-resistant Enterobacterales |
Cu |
Copper |
CuAF |
copper nanoferrite |
CZA |
Contezolid acefosamil |
CZD |
Contezolid |
DABCO |
Triethylenediamine |
DAR |
Darobactins |
DBOs |
Diazabicyclooctanones |
DBU |
1,8-Diazabicyclo [5.4.0]undec-7-ene |
DBU |
1,8-Diazabicyclo(5.4.0)undec-7-ene |
DCM |
Dichloromethane |
Ddl
|
D-alanyl-D-alanine synthetase
|
Ddl-B |
D-alanine-D-alanine ligase |
Ddn |
Deazaflavin-dependent nitroreductase |
DDQ |
2,3-Dichloro-5,6-dicyano-1,4-bezoquinone |
DIPEA |
N,N-Diisopropylethylamine |
DMAP |
4-Dimethylaminopyridine |
DMC |
Dimethyl carbonate |
DMF |
Dimethylformamide |
DMSO |
Dimethyl sulfoxide |
DPD |
(S)-4,5-dihydroxypentane-2,3-dione |
DprE1 |
Decaprenylphosphoryl-β-D-ribose 2′-epimerase |
DS |
Design space |
DSF |
Differential Scanning Fluorimetry |
DSPG |
Di-stearoyl-phosphatidylglycerol |
E4P |
D-erythrose-4-phosphate |
E4PDH |
Erythrose-4-phosphate dehydrogenase |
ECC |
Enterobacter cloacae complex |
EOCM |
Essential oil from Centipeda minima
|
EOOG |
Egg oil-organogel |
EOs |
Plant essential oils |
ESKAPE |
Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species pathogens |
Et3N |
Triethylamine |
EthR |
Transcriptional repressor |
EtOH |
Ethanol |
FBDD |
Fragment-based drug design |
FECL2 |
Iron(II) chloride |
FePPOPHydantoin
|
Porphyrin iron-based porous organic polymer |
Fts-Z |
Filamenting temperature-sensitive mutant Z |
G3P |
Glyceraldehyde-3-phosphate |
GA |
Glycyrrhizin |
GC-MS |
Gas chromatography-mass spectrometry |
GRA |
18β-glycyrrhetinic acid |
Gyr-B |
DNA gyrase B subunits |
H2CBD |
8,9-dihydrocannabidiol |
HAM |
Hamamelitannin |
HCl |
Hydrochloric acid |
HGT |
Horizontal gene transfer |
HTS |
High throughput screening |
I2
|
Iodine |
InhA |
2-trans-enoyl-acyl carrier protein reductase |
i-Pr2Net |
N,N-Diisopropylethylamine |
K2CO3 |
Potassium carbonate |
KI |
Potassium iodide |
KNCS |
Potassium thiocyanate |
KOH |
Potassium hydroxide |
Lf |
Lactoferrin |
LiOH |
Lithium hydroxide |
MATE |
Multidrug and Toxic Compound Extrusion |
MBC |
Minimum bactericidal concentration |
m-CPBA |
meta-Chloroperoxybenzoic acid |
MD
|
Molecular dynamics
|
MDR |
Multidrug resistance |
MEI |
Iodomethane |
MeOH, |
Methanol |
MIC |
Minimum inhibitory concentration |
MMC |
Mitomycin C |
MRSA |
Methicillin-resistant S. aureus
|
Ms |
Saturation magnetization |
MSSA |
Methicillin-sensitive Staphylococcus aureus
|
mtk-QSBER |
multitasking model for quantitative-structure biological effect relationships |
NaBH4
|
Sodium borohydride |
NaBH4
|
Sodium borohydride |
NaH |
Sodium hydride |
NaHCO3
|
Sodium bicarbonate |
NAOCH3 |
Sodium methoxide |
NAOH |
Sodium hydroxide |
NBS |
N-Bromosuccinimide |
n-Bu3SnH. |
Tributyltin hydride |
n-BuLi |
n-Butllithium |
NCS |
N-Chlorosuccinimide |
NIR |
Near-infrared |
NMR |
Nuclear magnetic resonance |
NO |
Nitric oxide |
NPET |
Nascent peptide exit tunnel |
NPs |
Nanoparticles |
NRPSs |
non-ribosomal peptide synthetases |
ODLs |
Odilorhabdins |
PABA |
p-aminobenzoic acid |
PACE |
Proteobacterial Antimicrobial Compound Efflux |
PBPs |
Penicillin-binding proteins |
PDA@FeS NPs |
ferrous sulfide-polydopamine nanoparticles |
Pd-C |
Palladium on carbon |
PE |
Phosphatidyl-ethanolamine |
PEITC |
Phenethyl isothiocyanate |
PGLEO |
Psidium guajava (guava) leaf essential oil |
PIPD1 |
Piperidinol-containing molecule |
PJI |
Prosthetic joint infection |
PKSs |
Polyketide synthases |
POCl3
|
Phosphoryl chloride |
PPA |
Polyphosphoric acid |
PTC |
Peptidyl transferase center |
QbD |
Quality by design |
QS |
Quorum Sensing |
RA |
Risk Assessment |
RIF-BSA-NPs |
Rifampicin-loaded bovine serum albumin nanoparticles |
RNAP |
RNA polymerase |
RND |
Resistance Nodulation Division |
ROS |
Reactive oxygen species |
ROS |
Reactive oxygen species () |
rt. |
Room temperature |
SAM (RaS) |
Radical S-adenosylmethionine |
SAR |
Structure-activity relationships |
Silver oxide |
Ag2O |
SMR |
Small Multidrug Resistance |
SSD |
Silver Sulphadiazine |
TB |
Tuberculosis |
TBAB |
Tetra-n- butylammonium bromide |
T-BUOH |
Tert-Butyl alcohol |
T-BUOK |
Potassium tert-butoxide |
TCA |
Tricarboxylic acid cycle |
Tf |
Transferrin |
THBTP |
Tetrahydro-1-benzothiophene |
THC |
Trans-Δ-9-tetrahydrocannabinol |
THF |
Tetrahydrofuran |
ThyX |
Thymidylate synthase |
TLM |
Thiolactomycin |
TPP |
Target product profile |
TQ
|
Thymoquinone
|
TriBE inhibitor |
Pyrimidoindole inhibitor |
TRPPs |
Tetracycline ribosomal protection proteins |
WHO |
World Health Organization |
XDR |
extensively drug resistant |
β-MGP |
β-D-galactopyranoside |